Blend Composition TB-500 Thymosin 4 Fragment 10mg BPC-157 Gastric Pentadecapeptide 10mg GHK-Cu Copper Tripeptide 50mg KPV -MSH Tripeptide 10mg Reference data KLOW Blend specifications Composition 10mg TB-500 + 10mg BPC-157 + 50mg GHK-Cu + 10mg KPV Total amount per vial 80mg co-lyophilized blend Components Four research peptides Appearance White to pale blue lyophilized powder (copper content) Solubility Soluble in bacteriostatic water Purity 99.41% Research applications Where KLOW Blend is used in research Areas of study described in the published literature

For the long-term prevention and treatment of cobalt (vitamin B12) deficiency in lambs, ewes and calves Each mL contains 3 mg hydroxocobalamin hydrochloride Long-acting formulation Proven in NZ conditions World-first microencapsulation technology Vitamin B12 levels are maintained for 6 months in replacement lambs injected with 1 ml at docking/tailing Flexible treatment options you can tailor dose to suit length of efficacy required in lambs New Zealand developed, trialled and made Dosage and Administration Shake well before and during use to ensure the product is fully re-suspended
Exclusion criteria were people unable to provide consent, aged under 18, currently pregnant, or who had used hormone therapies (oral contraceptives, GnRH agonist/antagonist, progestins, etc.) in the 3 months preceding study enrollment
Niedobr L-karnityny w organizmie czowieka Najczciej spotykany jest wtrny niedobr karnityny wynikajcy z niewystarczajcego spoywania substancji wraz z diet
For instance, an in vitro study showed that two forms of vitamin B 6 , pyridoxal and pyridoxal phosphate, inhibited the binding of GABA to postsynaptic receptors (16)
The peptide can raise systolic blood pressure by about 6 mmHg and diastolic by about 3 mmHg for a few hours after the dose